NeuroSense Therapeutics Ltd (NRSN) Stock Price, Quote, News & History

NRSNNASDAQ
$6.70
0.0640.96%
At close: Sep 10, 5:00 PM EST
$0.3399
-6.30-94.88%
Pre-Market: 3:00 AM EST
Stock Split: NeuroSense Therapeutics Ltd is expected to split Monday, September 14, 2026 with a ratio of 1:20

NeuroSense Therapeutics (NRSN) Stock Price, Quote, News & History | Benzinga

Loading...

Key Statistics

Open
-
Close
$6.70
Volume / Avg.
0 / 17.63K
Day Range
- - -
52 Wk Range
5.00 - 26.64
Market Cap
$644.76K
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
21
Short Interest
31.44%
Days to Cover
1.46

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-7.67M
Investing Cash Flow (TTM)
-8.00K
Financing Cash Flow (TTM)
4.43M
Free Cash Flow (TTM)
-7.68M
Capital Expenditure (TTM)
-8.00K
Net Change in Cash (TTM)
-3.25M

Analyst Trends and Forecast

2
Mar
1
Apr
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$13.18M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-126.73%
Earnings Yield % (FWD)
-9.72%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.82

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$166.00K
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$6.70
Volume / Avg.
0 / 17.63K
Day Range
- - -
52 Wk Range
5.00 - 26.64
Market Cap
$644.76K
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
21
Short Interest
31.44%
Days to Cover
1.46

About

Sector
Health Care
Industry
Biotechnology
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy NeuroSense Therapeutics (NRSN) stock?

A

You can purchase shares of NeuroSense Therapeutics (NASDAQ:NRSN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NeuroSense Therapeutics (NRSN) competitors?

Q

What is the forecast, or price target, for NeuroSense Therapeutics (NRSN) stock?

A

NeuroSense Therapeutics has a consensus price target of $166.67.

Q

What is the current price for NeuroSense Therapeutics (NRSN)?

A

The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $0.3399 last updated September 11, 2026 at 7:49 PM EDT.

Q

Does NeuroSense Therapeutics (NRSN) pay a dividend?

A

There are no upcoming dividends for NeuroSense Therapeutics.

Q

When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?

A

NeuroSense Therapeutics does not have any upcoming earnings scheduled.

Q

Is NeuroSense Therapeutics (NRSN) going to split?

A

There is no upcoming split for NeuroSense Therapeutics.

Q

What sector and industry does NeuroSense Therapeutics (NRSN) operate in?

A

NeuroSense Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.